Los Angeles Capital Management LLC Celldex Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 15,421 shares of CLDX stock, worth $302,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,421
Previous 6,738
128.87%
Holding current value
$302,868
Previous $228,000
70.61%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$176 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$99.5 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$92.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$76.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$73.7 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $919M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...